The Effects of Anesthetic Method on Cerebral Oxygen Saturation in Geriatric Patients Undergoing Transurethral Surgery
This study has been completed.
Sponsor:
Yonsei University
Information provided by:
Yonsei University
ClinicalTrials.gov Identifier:
NCT01147146
First received: June 17, 2010
Last updated: May 12, 2011
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The effects of anesthetic method on cerebral oxygen saturation in geriatric patients undergoing transurethral surgery.
| Condition | Intervention |
|---|---|
|
Surgery |
Drug: propofol, fentanyl, atracurium Drug: bupivacaine Drug: bupivacaine, Midazolam |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Primary Purpose: Prevention |
| Official Title: | The Effects of Anesthetic Method on Cerebral Oxygen Saturation in Geriatric Patients Undergoing Transurethral Surgery |
Resource links provided by NLM:
MedlinePlus related topics:
Oxygen Therapy
Drug Information available for:
Fentanyl
Fentanyl citrate
Propofol
Bupivacaine hydrochloride
Bupivacaine
Midazolam hydrochloride
Atracurium besylate
U.S. FDA Resources
Further study details as provided by Yonsei University:
| Enrollment: | 64 |
| Study Start Date: | June 2010 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Drug: propofol, fentanyl, atracurium
general anesthesia
Other Name: propofol 2mg/kg, fentanyl 50mg, atracurium 0.5mg/kg
Drug: bupivacaine
spinal anesthesia
Other Name: bupivacaine 8-10mg
Drug: bupivacaine, Midazolam
spinal anesthesia & sedation
Other Name: Bupivacine 8-10mg, Midazolam 0.5mg/kg
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- male patients (ASA physical status I and II) aged over 65 yrs and scheduled elective transurethral surgery
Exclusion Criteria:
- cardiovascular, renal, liver disease, or cerebrovascular disorder
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01147146
Locations
| Korea, Republic of | |
| Severance Hospital, Yonsei University College of Medicine | |
| Seoul, Korea, Republic of | |
Sponsors and Collaborators
Yonsei University
Investigators
| Principal Investigator: | Jeong-Yeon Hong, MD | Anesthesiology & Pain Medicine, Severance Hospital |
More Information
No publications provided
| Responsible Party: | Jeong-Yeon Hong / Associate Clinical Professor, Yonsei University, College of Medicine |
| ClinicalTrials.gov Identifier: | NCT01147146 History of Changes |
| Other Study ID Numbers: | 4-2010-0133 |
| Study First Received: | June 17, 2010 |
| Last Updated: | May 12, 2011 |
| Health Authority: | Korea: Food and Drug Administration |
Keywords provided by Yonsei University:
|
transurethral surgery |
Additional relevant MeSH terms:
|
Anesthetics Bupivacaine Midazolam Fentanyl Propofol Atracurium Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Nicotinic Antagonists Cholinergic Antagonists Cholinergic Agents Neurotransmitter Agents |
Molecular Mechanisms of Pharmacological Action Neuromuscular Nondepolarizing Agents Neuromuscular Blocking Agents Neuromuscular Agents Peripheral Nervous System Agents Anesthetics, Local Sensory System Agents Adjuvants, Anesthesia Anti-Anxiety Agents Tranquilizing Agents Psychotropic Drugs Hypnotics and Sedatives Anesthetics, Intravenous Anesthetics, General GABA Modulators |
ClinicalTrials.gov processed this record on May 23, 2013